KEGG   DRUG: AfelimomabHelp
Entry
D07436                      Drug                                   

Name
Afelimomab (INN)
Class
Other
 DG01936  TNF inhibitor
Remark
ATC code: 
Activity
Immunosuppressant, Anti-TNF-alpha antibody
Target
  Pathway
MAPK signaling pathway
Cytokine-cytokine receptor interaction
Apoptosis
TGF-beta signaling pathway
Antigen processing and presentation
Adipocytokine signaling pathway
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
     L04AB03 Afelimomab
      D07436  Afelimomab (INN)
Target-based classification of drugs [BR:br08310]
 Cytokines
  TNF family
   TNF-alpha
    Afelimomab
     D07436  Afelimomab (INN)
BRITE hierarchy
Other DBs
CAS: 
156227-98-4
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system